1-8 of 8
Stephen Yip
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers

Erica S. Tsang, Cameron J. Grisdale, Erin Pleasance, James T. Topham, Karen Mungall, Caralyn Reisle, Caleb Choo, Marcus Carreira, Reanne Bowlby, Joanna M. Karasinska, Daniel MacMillan, Laura M. Williamson, Eric Chuah, Richard A. Moore, Andrew J. Mungall, Yongjun Zhao, Basile Tessier-Cloutier, Tony Ng, Sophie Sun, Howard J. Lim, David F. Schaeffer, Daniel J. Renouf, Stephen Yip, Janessa Laskin, Marco A. Marra, Steven J.M. Jones, Jonathan M. Loree
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 522–531.
https://doi.org/10.1158/1078-0432.CCR-20-1900
Published: 19 January 2021
View article titled, Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers
Open the PDF for Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers in another window
Includes: Supplementary data
Journal Articles

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Alexandra Pender, Emma Titmuss, Erin D. Pleasance, Kevin Y. Fan, Hillary Pearson, Scott D. Brown, Cameron J. Grisdale, James T. Topham, Yaoqing Shen, Melika Bonakdar, Gregory A. Taylor, Laura M. Williamson, Karen L. Mungall, Eric Chuah, Andrew J. Mungall, Richard A. Moore, Jean-Michel Lavoie, Stephen Yip, Howard Lim, Daniel J. Renouf, Sophie Sun, Robert A. Holt, Steven J.M. Jones, Marco A. Marra, Janessa Laskin
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (1): 202–212.
https://doi.org/10.1158/1078-0432.CCR-20-1163
Published: 04 January 2021
View article titled, Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors
Open the PDF for Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract A12: Analysis of advanced quantitative computed tomography imaging features in predicting the surgical resectability of advanced epithelial ovarian cancer

Paul A. DiSilvestro, Jessica DiSilvestro, Jonathan S. Ball, Stephen Yip, Anna Schwarzbach, Katherine M. Moxley
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A12.
https://doi.org/10.1158/1557-3265.OVCA19-A12
Published: 01 July 2020
View article titled, Abstract A12: Analysis of advanced quantitative computed tomography imaging features in predicting the surgical resectability of advanced epithelial ovarian cancer
Journal Articles

NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma

Martin R. Jones, Laura M. Williamson, James T. Topham, Michael K.C. Lee, Angela Goytain, Julie Ho, Robert E. Denroche, GunHo Jang, Erin Pleasance, Yaoquing Shen, Joanna M. Karasinska, John P. McGhie, Sharlene Gill, Howard J. Lim, Malcolm J. Moore, Hui-li Wong, Tony Ng, Stephen Yip, Wei Zhang, Sara Sadeghi, Carolyn Reisle, Andrew J. Mungall, Karen L. Mungall, Richard A. Moore, Yussanne Ma, Jennifer J. Knox, Steven Gallinger, Janessa Laskin, Marco A. Marra, David F. Schaeffer, Steven J.M. Jones, Daniel J. Renouf
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4674–4681.
https://doi.org/10.1158/1078-0432.CCR-19-0191
Published: 01 August 2019
View article titled, <em>NRG1</em> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <em>KRAS</em> Wild-Type Pancreatic Ductal Adenocarcinoma
Open the PDF for <em>NRG1</em> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <em>KRAS</em> Wild-Type Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer

Eric Y. Zhao, Yaoqing Shen, Erin Pleasance, Katayoon Kasaian, Sreeja Leelakumari, Martin Jones, Pinaki Bose, Carolyn Ch'ng, Caralyn Reisle, Peter Eirew, Richard Corbett, Karen L. Mungall, Nina Thiessen, Yussanne Ma, Jacqueline E. Schein, Andrew J. Mungall, Yongjun Zhao, Richard A. Moore, Wendie Den Brok, Sheridan Wilson, Diego Villa, Tamara Shenkier, Caroline Lohrisch, Stephen Chia, Stephen Yip, Karen Gelmon, Howard Lim, Daniel Renouf, Sophie Sun, Kasmintan A. Schrader, Sean Young, Ian Bosdet, Aly Karsan, Janessa Laskin, Marco A. Marra, Steven J.M. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7521–7530.
https://doi.org/10.1158/1078-0432.CCR-17-1941
Published: 14 December 2017
View article titled, Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
Open the PDF for Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PR02: Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma

Pinaki Bose, Erin Pleasance, Martin Jones, Yaoqing Shen, Carolyn Ch'ng, Caralyn Reisle, Jacqueline E. Schein, Andrew Mungall, Richard Moore, Yussanne Ma, Brandon S. Sheffield, Thomas Thomson, Steven Rasmussen, Christopher Lee, Stephen Yip, Marco A. Marra, Janessa Laskin, Cheryl Ho, Steven J. M. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): PR02.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-PR02
Published: 03 January 2016
View article titled, Abstract PR02: Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma
Journal Articles

Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Anna Luisa Di Stefano, Alessandra Fucci, Veronique Frattini, Marianne Labussiere, Karima Mokhtari, Pietro Zoppoli, Yannick Marie, Aurelie Bruno, Blandine Boisselier, Marine Giry, Julien Savatovsky, Mehdi Touat, Hayat Belaid, Aurelie Kamoun, Ahmed Idbaih, Caroline Houillier, Feng R. Luo, Jean-Charles Soria, Josep Tabernero, Marica Eoli, Rosina Paterra, Stephen Yip, Kevin Petrecca, Jennifer A. Chan, Gaetano Finocchiaro, Anna Lasorella, Marc Sanson, Antonio Iavarone
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3307–3317.
https://doi.org/10.1158/1078-0432.CCR-14-2199
Published: 14 July 2015
View article titled, Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
Open the PDF for Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma in another window
Includes: Supplementary data
Journal Articles

MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

Stephen Yip, Jiangyong Miao, Daniel P. Cahill, A. John Iafrate, Ken Aldape, Catherine L. Nutt, David N. Louis
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4622–4629.
https://doi.org/10.1158/1078-0432.CCR-08-3012
Published: 15 July 2009
View article titled, <em>MSH6</em> Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
Open the PDF for <em>MSH6</em> Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance in another window
Includes: Supplementary data